Hyperfine, Inc. ( HYPR) - Key Metrics
HYPR Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.04 | -$0.09 | -$0.07 | -$0.07 |
| 2026Q1 | $0.04 | -$0.09 | -$0.09 | -$0.09 |
| 2025Q4 | $0.06 | -$0.06 | -$0.06 | -$0.06 |
| 2025Q3 | $0.04 | -$0.14 | -$0.07 | -$0.07 |
| 2025Q2 | $0.03 | -$0.12 | -$0.10 | -$0.11 |
HYPR Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -3.75 |
| 2026Q1 | 0% | -3.00 |
| 2025Q4 | 0% | -3.90 |
| 2025Q3 | 0% | -2.59 |
| 2025Q2 | 0% | -1.50 |
HYPR
Price: $0.90
52 week price:
Earnings Per Share: -0.37 USD
Exchange: NGM
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 182898
Market Capitalization: 102.4 million